From improved glycemic control and weight management to cardiovascular benefits, blood pressure regulation, and potential impacts on liver health, neuroprotection, and gastrointestinal function, semaglutide represents a multifaceted treatment option
Research is ongoing, but evidence remains preliminary
Ipamorelin, a new growth-hormone-releasing peptide, induces growth hormone release in a specific and selective manner animal Raun K, Hansen BS, Johansen NL, et al
COVID-19 and diabetes: is metformin a friend or foe
"India and China alone represent about a quarter of the worlds adult obese population, and the availability of generic semaglutide will be a big shift in how these countries manage these populations." The market is ripe in countries where semaglutide goes off patent next year, as close to one-third of the worlds adults with obesity live in those countries, says Aurelio Arias, director of thought leadership at Iqvia, a health-information company
Esbaugh, 2023)